Skip to main content
NCBI home page
Heart logoLink to Heart
. 2005 Jun;91(Suppl 3):iii20–iii23. doi: 10.1136/hrt.2005.060269

Coronary stents: in these days of climate change should all stents wear coats?

R Lowe, I Menown, G Nogareda, I Penn
PMCID: PMC1876356  PMID: 15919648

Full Text

The Full Text of this article is available as a PDF (60.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alt E., Haehnel I., Beilharz C., Prietzel K., Preter D., Stemberger A., Fliedner T., Erhardt W., Schömig A. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Circulation. 2000 Mar 28;101(12):1453–1458. doi: 10.1161/01.cir.101.12.1453. [DOI] [PubMed] [Google Scholar]
  2. Antoniucci D., Bartorelli A., Valenti R., Montorsi P., Santoro G. M., Fabbiocchi F., Bolognese L., Loaldi A., Trapani M., Trabattoni D. Clinical and angiographic outcome after coronary arterial stenting with the carbostent. Am J Cardiol. 2000 Apr 1;85(7):821–825. doi: 10.1016/s0002-9149(99)00874-7. [DOI] [PubMed] [Google Scholar]
  3. Atalar E., Haznedaroğlu I., Aytemir K., Aksöyek S., Ovünç K., Oto A., Ozmen F. Effects of stent coating on platelets and endothelial cells after intracoronary stent implantation. Clin Cardiol. 2001 Feb;24(2):159–164. doi: 10.1002/clc.4960240211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartorelli Antonio L., Trabattoni Daniela, Montorsi Piero, Fabbiocchi Franco, Galli Stefano, Ravagnani Paolo, Grancini Luca, Cozzi Sergio, Loaldi Alessandro. Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study. Catheter Cardiovasc Interv. 2002 Feb;55(2):150–156. doi: 10.1002/ccd.10037. [DOI] [PubMed] [Google Scholar]
  5. Beaudry Y., Sze S., Fagih B., Constance C., Kwee R. Six-month results of small vessel stenting (2.0-2.8 mm) with the Biodivysio SV stent. J Invasive Cardiol. 2001 Sep;13(9):628–631. [PubMed] [Google Scholar]
  6. Beythien C., Gutensohn K., Bau J., Hamm C. W., Kühnl P., Meinertz T., Terres W. Influence of stent length and heparin coating on platelet activation: a flow cytometric analysis in a pulsed floating model. Thromb Res. 1999 Apr 15;94(2):79–86. doi: 10.1016/s0049-3848(98)00198-4. [DOI] [PubMed] [Google Scholar]
  7. Bickel C., Rupprecht H. J., Darius H., Binz C., Hauröder B., Krummenauer F., Meyer J. Substantial reduction of platelet adhesion by heparin-coated stents. J Interv Cardiol. 2001 Aug;14(4):407–413. doi: 10.1111/j.1540-8183.2001.tb00350.x. [DOI] [PubMed] [Google Scholar]
  8. Blezer R., Cahalan L., Cahalan P. T., Lindhout T. Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generation. Blood Coagul Fibrinolysis. 1998 Jul;9(5):435–440. doi: 10.1097/00001721-199807000-00006. [DOI] [PubMed] [Google Scholar]
  9. Boland J. L., Corbeij H. AM, Van Der Giessen W., Seabra-Gomes R., Suryapranata H., Wijns W., Hanet C., Suttorp M. J., Buller C., Bonnier J. JRM. Multicenter evaluation of the phosphorylcholine-coated biodivYsio stent in short de novo coronary lesions: The SOPHOS study. Int J Cardiovasc Intervent. 2000 Dec;3(4):215–225. doi: 10.1080/14628840050515966. [DOI] [PubMed] [Google Scholar]
  10. Buergler J. M., Tio F. O., Schulz D. G., Khan M. M., Mazur W., French B. A., Raizner A. E., Ali N. M. Use of nitric-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs. Coron Artery Dis. 2000 Jun;11(4):351–357. doi: 10.1097/00019501-200006000-00009. [DOI] [PubMed] [Google Scholar]
  11. Carrié D., Khalifé K., Hamon M., Citron B., Monassier J. P., Sabatier R., Lipiecky J., Mourali S., Sarfaty L., Elbaz M. Initial and follow-up results of the Tenax coronary stent. J Interv Cardiol. 2001 Feb;14(1):1–5. doi: 10.1111/j.1540-8183.2001.tb00702.x. [DOI] [PubMed] [Google Scholar]
  12. Christensen K., Larsson R., Emanuelsson H., Elgue G., Larsson A. Coagulation and complement activation. Biomaterials. 2001 Feb;22(4):349–355. doi: 10.1016/s0142-9612(00)00190-3. [DOI] [PubMed] [Google Scholar]
  13. Cumberland D. C., Gunn J., Malik N., Holt C. M. Biomimicry 1: PC. Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):149–150. [PubMed] [Google Scholar]
  14. De Scheerder I., Szilard M., Yanming H., Ping X. B., Verbeken E., Neerinck D., Demeyere E., Coppens W., Van de Werf F. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model. J Invasive Cardiol. 2000 Aug;12(8):389–394. [PubMed] [Google Scholar]
  15. De Scheerder I., Verbeken E., Van Humbeeck J. Metallic surface modification. Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):139–144. [PubMed] [Google Scholar]
  16. Do Young S., Kao Edward Y., Ganaha Fumikiyo, Minamiguchi Hiroki, Sugimoto Koji, Lee Jane, Elkins Christopher J., Amabile Philippe G., Kuo Michael D., Wang David S. In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits. Radiology. 2003 Dec 29;230(2):377–382. doi: 10.1148/radiol.2302020417. [DOI] [PubMed] [Google Scholar]
  17. Edelman E. R., Seifert P., Groothuis A., Morss A., Bornstein D., Rogers C. Gold-coated NIR stents in porcine coronary arteries. Circulation. 2001 Jan 23;103(3):429–434. doi: 10.1161/01.cir.103.3.429. [DOI] [PubMed] [Google Scholar]
  18. Elbaz Meyer, El Mokhtar Elyes, Fourcade Joelle, Mourali Sami, Hobeika Robert, Carrié Didier, Puel Jacques. Does stent design affect the long-term outcome after coronary stenting? Catheter Cardiovasc Interv. 2002 Jul;56(3):305–311. doi: 10.1002/ccd.10240. [DOI] [PubMed] [Google Scholar]
  19. Fischman D. L., Leon M. B., Baim D. S., Schatz R. A., Savage M. P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. doi: 10.1056/NEJM199408253310802. [DOI] [PubMed] [Google Scholar]
  20. Fleser Paul S., Nuthakki Vijay K., Malinzak Lauren E., Callahan Rose E., Seymour Marilyn L., Reynolds Melissa M., Merz Scott I., Meyerhoff Mark E., Bendick Phillip J., Zelenock Gerald B. Nitric oxide-releasing biopolymers inhibit thrombus formation in a sheep model of arteriovenous bridge grafts. J Vasc Surg. 2004 Oct;40(4):803–811. doi: 10.1016/j.jvs.2004.07.007. [DOI] [PubMed] [Google Scholar]
  21. Fournier J. A., Calabuig J., Merchán A., Augé J. M., Melgares R., Colman T., Martín De Dios R., Insag L., Santos I. Resultados iniciales y seguimiento clínico a 6 meses tras el implante de un stent coronario recubierto de carburo de silicio. Rev Esp Cardiol. 2001 May;54(5):567–572. doi: 10.1016/s0300-8932(01)76358-0. [DOI] [PubMed] [Google Scholar]
  22. Galli M., Bartorelli A., Bedogni F., DeCesare N., Klugmann S., Maiello L., Miccoli F., Moccetti T., Onofri M., Paolillo V. Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent. J Invasive Cardiol. 2000 Sep;12(9):452–458. [PubMed] [Google Scholar]
  23. Gershlick A. H., Baron J. Dealing with in-stent restenosis. Heart. 1998 Apr;79(4):319–323. doi: 10.1136/hrt.79.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gotman I. Characteristics of metals used in implants. J Endourol. 1997 Dec;11(6):383–389. doi: 10.1089/end.1997.11.383. [DOI] [PubMed] [Google Scholar]
  25. Grenadier Ehud, Roguin Ariel, Hertz Izhack, Peled Benjamin, Boulos Monther, Nikolsky Eugenia, Amikam Shlomo, Kerner Arthur, Cohen Silviu, Beyar Rafael. Stenting very small coronary narrowings (< 2 mm) using the biocompatible phosphorylcholine-coated coronary stent. Catheter Cardiovasc Interv. 2002 Mar;55(3):303–308. doi: 10.1002/ccd.10130. [DOI] [PubMed] [Google Scholar]
  26. Gutensohn K., Beythien C., Bau J., Fenner T., Grewe P., Koester R., Padmanaban K., Kuehnl P. In vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res. 2000 Sep 15;99(6):577–585. doi: 10.1016/s0049-3848(00)00295-4. [DOI] [PubMed] [Google Scholar]
  27. Haude Michael, Konorza Thomas F. M., Kalnins Uldis, Erglis Andrejs, Saunamäki Kari, Glogar Helmut D., Grube Eberhard, Gil Robert, Serra Antonio, Richardt Hans G. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation. 2003 Mar 11;107(9):1265–1270. doi: 10.1161/01.cir.0000053442.64637.34. [DOI] [PubMed] [Google Scholar]
  28. Hehrlein C., Zimmermann M., Metz J., Ensinger W., Kübler W. Influence of surface texture and charge on the biocompatibility of endovascular stents. Coron Artery Dis. 1995 Jul;6(7):581–586. [PubMed] [Google Scholar]
  29. Herrmann R., Schmidmaier G., Märkl B., Resch A., Hähnel I., Stemberger A., Alt E. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost. 1999 Jul;82(1):51–57. [PubMed] [Google Scholar]
  30. Heublein B, Pethig K, Elsayed AM. Silicon Carbide Coating Ñ A Semiconducting Hybrid Design of Coronary Stents Ñ A Feasibility Study. J Invasive Cardiol. 1998 Jun;10(5):255–262. [PubMed] [Google Scholar]
  31. Hoffmann Rainer, Mintz Gary S., Haager Philipp K., Bozoglu Togul, Grube Eberhard, Gross Michael, Beythien Christian, Mudra Harald, vom Dahl Jürgen, Hanrath Peter. Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. Am J Cardiol. 2002 Jun 15;89(12):1360–1364. doi: 10.1016/s0002-9149(02)02347-0. [DOI] [PubMed] [Google Scholar]
  32. Kastrati A., Mehilli J., Dirschinger J., Dotzer F., Schühlen H., Neumann F. J., Fleckenstein M., Pfafferott C., Seyfarth M., Schömig A. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation. 2001 Jun 12;103(23):2816–2821. doi: 10.1161/01.cir.103.23.2816. [DOI] [PubMed] [Google Scholar]
  33. Kastrati A., Schömig A., Dirschinger J., Mehilli J., von Welser N., Pache J., Schühlen H., Schilling T., Schmitt C., Neumann F. J. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation. 2000 May 30;101(21):2478–2483. doi: 10.1161/01.cir.101.21.2478. [DOI] [PubMed] [Google Scholar]
  34. Kereiakes Dean J., Cox David A., Hermiller James B., Midei Mark G., Bachinsky William B., Nukta E. Dean, Leon Martin B., Fink Stanley, Marin Linda, Lansky Alexandra J. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003 Aug 15;92(4):463–466. doi: 10.1016/s0002-9149(03)00669-6. [DOI] [PubMed] [Google Scholar]
  35. Korkmaz Mehmet Emin, Tayfun Egemen, Müderrisoglu Haldun, Yildirir Aylin, Ozin Bülent, Uluçam Melek, Turan Münire. Carbon coating of stents has no effect on inflammatory response to primary stent deployment. Angiology. 2002 Sep-Oct;53(5):563–568. doi: 10.1177/000331970205300510. [DOI] [PubMed] [Google Scholar]
  36. Kuiper K. K., Robinson K. A., Chronos N. A., Cui J., Palmer S. J., Nordrehaug J. E. Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scand Cardiovasc J. 1998;32(5):261–268. doi: 10.1080/14017439850139843. [DOI] [PubMed] [Google Scholar]
  37. Lewis A. L., Furze J. D., Small S., Robertson J. D., Higgins B. J., Taylor S., Ricci D. R. Long-term stability of a coronary stent coating post-implantation. J Biomed Mater Res. 2002;63(6):699–705. doi: 10.1002/jbm.10387. [DOI] [PubMed] [Google Scholar]
  38. Lewis A. L., Tolhurst L. A., Stratford P. W. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials. 2002 Apr;23(7):1697–1706. doi: 10.1016/s0142-9612(01)00297-6. [DOI] [PubMed] [Google Scholar]
  39. Liistro F., Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart. 2001 Sep;86(3):262–264. doi: 10.1136/heart.86.3.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Malik N., Gunn J., Shepherd L., Crossman D. C., Cumberland D. C., Holt C. M. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. J Invasive Cardiol. 2001 Mar;13(3):193–201. [PubMed] [Google Scholar]
  41. McNair A. M. Using hydrogel polymers for drug delivery. Med Device Technol. 1996 Dec;7(10):16–22. [PubMed] [Google Scholar]
  42. Nakayama Y., Ji-Youn K., Nishi S., Ueno H., Matsuda T. Development of high-performance stent: gelatinous photogel-coated stent that permits drug delivery and gene transfer. J Biomed Mater Res. 2001 Dec 15;57(4):559–566. doi: 10.1002/1097-4636(20011215)57:4<559::aid-jbm1202>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  43. New Gishel, Moses Jeffrey W., Roubin Gary S., Leon Martin B., Colombo Antonio, Iyer Sriram S., Tio Fermin O., Mehran Roxana, Kipshidze Nicholas. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model. Catheter Cardiovasc Interv. 2002 Oct;57(2):266–271. doi: 10.1002/ccd.10339. [DOI] [PubMed] [Google Scholar]
  44. Ozbek C., Heisel A., Gross B., Bay W., Schieffer H. Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation. Cathet Cardiovasc Diagn. 1997 May;41(1):71–78. doi: 10.1002/(sici)1097-0304(199705)41:1<71::aid-ccd17>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  45. Rothman M., Serruys P., Grollier G., Hoorntje J., van Den Bos A., Wijns W., Gershlick A., Van Es G., Melkert R., Eijgelshoven M. Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent Investigation (EASI). Catheter Cardiovasc Interv. 2001 Feb;52(2):249–259. doi: 10.1002/1522-726x(200102)52:2<249::aid-ccd1060>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  46. Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. doi: 10.1056/NEJM199408253310801. [DOI] [PubMed] [Google Scholar]
  47. Serruys P. W., van Hout B., Bonnier H., Legrand V., Garcia E., Macaya C., Sousa E., van der Giessen W., Colombo A., Seabra-Gomes R. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet. 1998 Aug 29;352(9129):673–681. doi: 10.1016/s0140-6736(97)11128-x. [DOI] [PubMed] [Google Scholar]
  48. Tanigawa N., Sawada S., Kobayashi M. Reaction of the aortic wall to six metallic stent materials. Acad Radiol. 1995 May;2(5):379–384. doi: 10.1016/s1076-6332(05)80338-1. [DOI] [PubMed] [Google Scholar]
  49. Tárnok A., Mahnke A., Müller M., Zotz R. J. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation. Cytometry. 1999 Feb 15;38(1):30–39. doi: 10.1002/(sici)1097-0320(19990215)38:1<30::aid-cyto5>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  50. Verheye S., Salame M. Y., Robinson K. A., Post M. J., Carrozza J. P., Jr, Baim D. S., Sigwart U., King S. B., 3rd, Chronos N. A. Short- and long-term histopathologic evaluation of stenting using a self-expanding nitinol stent in pig carotid and iliac arteries. Catheter Cardiovasc Interv. 1999 Nov;48(3):316–323. doi: 10.1002/(sici)1522-726x(199911)48:3<316::aid-ccd19>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  51. Virmani Renu, Liistro Francesco, Stankovic Goran, Di Mario Carlo, Montorfano Matteo, Farb Andrew, Kolodgie Frank D., Colombo Antonio. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002 Nov 19;106(21):2649–2651. doi: 10.1161/01.cir.0000041632.02514.14. [DOI] [PubMed] [Google Scholar]
  52. Vrolix M. C., Legrand V. M., Reiber J. H., Grollier G., Schalij M. J., Brunel P., Martinez-Elbal L., Gomez-Recio M., Bär F. W., Bertrand M. E. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol. 2000 Aug 15;86(4):385–389. doi: 10.1016/s0002-9149(00)00951-6. [DOI] [PubMed] [Google Scholar]
  53. Whelan D. M., van der Giessen W. J., Krabbendam S. C., van Vliet E. A., Verdouw P. D., Serruys P. W., van Beusekom H. M. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart. 2000 Mar;83(3):338–345. doi: 10.1136/heart.83.3.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wöhrle J., Al-Khayer E., Grötzinger U., Schindler C., Kochs M., Hombach V., Höher M. Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome. Eur Heart J. 2001 Oct;22(19):1808–1816. doi: 10.1053/euhj.2001.2608. [DOI] [PubMed] [Google Scholar]
  55. vom Dahl Jürgen, Haager Philipp K., Grube Eberhard, Gross Michael, Beythien Christian, Kromer Eckhard P., Cattelaens Norbert, Hamm Christian W., Hoffmann Rainer, Reineke Thorsten. Effects of gold coating of coronary stents on neointimal proliferation following stent implantation. Am J Cardiol. 2002 Apr 1;89(7):801–805. doi: 10.1016/s0002-9149(02)02188-4. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES